© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Inside this month's issue of Contemporary OB/GYN®
In this issue, physician-authors discuss the new ASCCP guidelines, best practices and safety recommendations for hysterosalpingography, a new approach to prenatal care, and more.
Quality of life in women with deep infiltrating endometriosis and combined oral contraceptives
January 20, 2022
There are a number of effective treatments, but a recent study sought to investigate how well oral contraceptives in particular could help reduce symptoms—while preserving sexual quality of life—in women with particularly severe forms of endometriosis.
Maternal deaths caused by chronic hypertension continue to rise
January 20, 2022
Additionally, the study showed a 15-fold increase in maternal mortality rates associated with chronic hypertension over the 40-year study period.
Breastfeeding reduces women’s risk of CVD
January 19, 2022
These mothers are approximately 17% less likely to die from cardiovascular disease, 14% less likely to develop coronary heart disease, and 12% less likely to suffer a stroke, the data show.
Relugolix for treating uterine fibroids
January 19, 2022
A phase 2, multicenter study has found relugolix (Myfembree; Myovant Sciences) significantly decreases menstrual blood loss in women with uterine leiomyomas and is mostly well tolerated.Relugolix is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Microbial interplay of recurrent vulvovaginal candidiasis pathobiology
January 19, 2022
A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.